经中国证券监督管理委员会证监许可〔2017〕1778号文核准，并经上海证券交易所同意，公司由主承销 商中信证券股份有限公司采用网下向符合条件的投资者询价配售与网上向持有上海市场非限售A股股份 市值的社会公众投资者定价发行相结合的方式，向社会公众公开发行人民币普通股(A股)股票7,000万 股，发行价为每股人民币19.52元，共计募集资金136,640.00万元，坐扣承销及保荐费后的募集资金为 129,140.00万元，已由主承销商中信证券股份有限公司于2017年10月24日汇入公司募集资金监管账户。 根据中国证券监督管理委员会《关于核准合盛硅业股份有限公司非公开发行股票的批复》(证监许可 〔2021〕508号)，公司由主承销商中信证券股份有限公司采用代销方式，向向自然人罗燚、罗烨栋非公 开发行人民币普通股(A股)股票136,165,577股，发行价为每股人民币18.36元，共计募集资金 2,499,999,993.72元，坐扣承销和保荐费用4,500,000.00元后的募集资金为2,495,499,993.72元，已由主承 销商中信证券股份有限公司于2021年6月4日汇入公司募集资金监管账户。 经中国证券监督 ...

兴图新科于2020年1月6日在上交所科创板上市，发行数量为1,840.00万股，发行价格为28.21元/ 股。兴图新科上市的保荐机构（主承销商）为中泰证券股份有限公司，保荐代表人为陈胜可、马闪亮。 兴图新科于上市后第三个交易日（2020年1月8日）盘中创下最高价60.89元，为该股上市以来最高 价。 兴图新科首次公开发行股票募集资金总额为51,906.40万元，募集资金净额46,622.76万元。该公司最 终募集资金净额较原计划多6037.93万元。 兴图新科2019年12月30日披露的招股书显示，公司拟募集资 金40,584.83万元，计划用于基于云联邦架构的军用视频指挥平台升级及产业化项目、研发中心建设项 目、补充流动资金。 中国经济网北京1月29日讯 兴图新科(688081.SH)昨晚披露2025年度业绩预告。经财务部门初步测 算，公司预计2025年度实现归属于母公司所有者的净利润-7,000.00万元到-5,800.00万元，与上年同期 （法定披露数据）相比，亏损将减少1,066.38万元到2,266.38万元，同比亏损收窄13.22%到28.10%。 公司预计2025年度实现归属于母公司所有者的扣除 ...

芯碁微装募集资金总额为4.60亿元，扣除发行费用后，募集资金净额为4.16亿元。芯碁微装最终募 集资金净额比原计划少5708.17万元。芯碁微装2021年3月29日披露的招股说明书显示，公司拟募集资金 4.73亿元，其中，2.08亿元用于高端PCB激光直接成像（LDI）设备升级迭代项目，9380.00万元用于晶 圆级封装（WLP）直写光刻设备产业化项目，1.08亿元用于平板显示（FPD）光刻设备研发项目， 6355.00万元用于微纳制造技术研发中心建设项目。 中国经济网北京1月22日讯 芯碁微装(688630.SH)昨日晚间发布关于控股股东、实际控制人减持股份 结果公告称，本次减持计划实施前，合肥芯碁微电子装备股份有限公司（以下简称"公司"）控股股东、 实际控制人程卓直接持有公司股份36,787,490股，占公司总股本的27.92%。上述股份均来源于公司首次 公开发行前取得的股份，并已上市流通。 公司于2025年10月1日在上海证券交易所网站披露了《控股股东、实际控制人减持股份计划公告》 （公告编号：2025-046），公司控股股东、实际控制人程卓拟通过集中竞价和大宗交易相结合的方式减 持不超过2,634,8 ...

Core Viewpoint - Tianyu Biological (603717.SH) is currently trading at 7.68 yuan, reflecting a decline of 2.04% and is in a state of breaking its initial public offering price [1] Group 1: Company Overview - Tianyu Biological was previously known as Tianyu Ecology and will officially change its name on August 21, 2024, while retaining its stock code 603717 [1] - The company was listed on the Shanghai Stock Exchange on March 27, 2017, with an issuance of 43.1779 million shares at a price of 14.63 yuan per share [1] Group 2: Fundraising and Financials - The total amount raised from the initial public offering was 631.6927 million yuan, with a net amount of 570.1861 million yuan after expenses [2] - The total issuance costs for the IPO were 61.5066 million yuan, including an underwriting fee of 52.7196 million yuan [3] - Tianyu Biological's previous fundraising totaled 1.034 billion yuan, with a non-public offering of 48.35 million shares at a price of 8.32 yuan per share, raising 402.272 million yuan [4][5]

Group 1 - The core point of the news is that Xi Ling Power (300733) announced a share reduction plan by its actual controller, Yu Yinglian, who intends to reduce her holdings through block trading [1] - Yu Yinglian holds 39,748,806 shares, representing 13.11% of the total share capital after excluding repurchased shares, and plans to reduce her holdings by 6,061,737 shares, which is 2.00% of the total share capital [1] - The planned reduction is expected to generate approximately 117 million yuan based on the closing price of 19.32 yuan per share [1] Group 2 - Xi Ling Power was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on January 16, 2018, with an initial offering price of 12.90 yuan per share, raising a total of 516 million yuan [1] - The net proceeds from the initial public offering amounted to 472 million yuan after deducting issuance costs, with specific allocations for various projects including 162 million yuan for engine belt wheel production line upgrades [1] - The total fundraising amount since the company's listing has reached 997 million yuan [4]

Core Viewpoint - Loushow Technology (002617.SZ) announced a significant share reduction by its major shareholder, Loushow Group, and its concerted parties, indicating a potential shift in ownership dynamics and investor sentiment towards the company [1][2]. Group 1: Share Reduction Details - Loushow Group and its concerted parties reduced their holdings by 16,229,600 shares, representing 0.84% of the total share capital, through block and centralized trading on December 22-23, 2025 [1]. - The total planned reduction is up to 57,275,218 shares, or 3% of the total share capital, as previously disclosed on November 26, 2025 [1][2]. - Prior to the transaction, Loushow Group and its concerted parties held 233,129,832 shares, accounting for 12.12% of the total share capital, which decreased to 216,900,232 shares, or 11.28%, post-transaction [2]. Group 2: Financial Implications - The weighted average price of Loushow Technology shares during the reduction period was 7.811 yuan, leading to an estimated reduction amount of approximately 12,676.94 million yuan [2]. - Since its listing in 2011, Loushow Technology has raised a total of 6 times, accumulating 6.719 billion yuan, with the initial public offering raising 540 million yuan and subsequent issuances raising 6.179 billion yuan [2]. Group 3: Company Background - Loushow Technology was listed on the Shenzhen Stock Exchange on September 20, 2011, with an initial issue price of 18 yuan per share [3]. - The company has engaged in multiple fundraising activities, including a public offering and several private placements, to support its growth and operational needs [4][5][6]. - The company is currently planning to issue H-shares and list on the Hong Kong Stock Exchange, indicating a strategic move to expand its market presence [7].

Core Viewpoint - The company, Luxshare Technology, announced a significant share reduction by its major shareholders, which has implications for its stock performance and investor sentiment [1][2]. Shareholder Reduction - Luxshare Group and its concerted parties reduced their holdings by 27,880,900 shares, representing 1.45% of the company's total share capital [1]. - The reduction occurred between December 18 and 19, 2025, through block trades and centralized transactions [1]. - The cash amount generated from this reduction is approximately 217 million yuan, based on a weighted average price of 7.77 yuan per share during the reduction period [2]. Shareholding Structure - Luxshare Group is the controlling shareholder, with key individuals such as Lu Xiaojun and Li Boying identified as actual controllers [2]. - The total planned reduction by Luxshare Group and its concerted parties is up to 57,275,218 shares, which is not more than 3% of the total share capital after excluding shares in the company's repurchase account [2]. Fundraising History - Since its listing in 2011, Luxshare Technology has raised funds six times, totaling 6.719 billion yuan, including an initial public offering (IPO) that raised 540 million yuan [2]. - The company has conducted five additional issuances, raising 6.179 billion yuan [2]. Future Plans - The company is currently planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with relevant intermediaries [7].

Group 1 - The stock price of Mingguan New Materials (688560.SH) fell by 3.82% to 14.10 yuan, indicating it is currently in a state of decline since its IPO [1] - Mingguan New Materials was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 24, 2020, with an initial offering price of 15.87 yuan per share and a total issuance of 41.022 million shares [1] - The total amount raised from the IPO was approximately 651 million yuan, with a net amount of about 573 million yuan, exceeding the original plan by 160 million yuan [1] Group 2 - On December 8, 2022, Mingguan New Materials announced the issuance of A-shares to specific investors, raising approximately 1.675 billion yuan at an issue price of 45.02 yuan per share [2] - After deducting issuance costs, the actual net amount raised was approximately 1.656 billion yuan, with 37.214 million shares included in the capital stock [2] - The total funds raised from both the IPO and the subsequent issuance amount to approximately 2.326 billion yuan [2]

Core Viewpoint - The company Yiheda (301029.SZ) disclosed a significant reduction in shareholding by its controlling shareholder and actual controller, Jin Liguo, along with associated parties, which has triggered a reporting obligation due to a decrease of 1% in shareholding [1] Group 1: Shareholding Changes - The controlling shareholder and associated parties reduced their holdings by a total of 6,554,500 shares, representing a decrease of 1.03% from December 2 to December 4, 2025 [2] - As of the date of the equity change, the total shareholding of the reporting parties stands at 22.93% [1] Group 2: Financial Details - The reduction in shareholding allowed the shareholders to cash out approximately 170 million yuan, based on an average stock price of 25.88 yuan during the reduction period [2] - Yiheda was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on July 23, 2021, with an initial public offering of 40.01 million shares at a price of 14.14 yuan per share, raising a total of 566 million yuan [2] - The actual net fundraising amount after deducting issuance costs was 504 million yuan, which was 642 million yuan less than the original plan of 1.146 billion yuan [2][4] Group 3: Fundraising and Costs - The total fundraising amount from two rounds of financing by Yiheda amounts to 1.436 billion yuan [4] - The issuance costs for the initial public offering were approximately 61.4 million yuan, with the underwriter, Dongguan Securities, receiving 47.17 million yuan in fees [3]

Core Viewpoint - The company has adjusted its fundraising plan for a specific stock issuance, reducing the total amount from a maximum of 4.8 billion yuan to 4.788 billion yuan while maintaining the intended use of funds [1] Fundraising Adjustment - The total amount to be raised has been adjusted to not exceed 4.788 billion yuan from the original 4.8 billion yuan [1] - The intended use of the raised funds remains unchanged, which includes projects for the annual production of 320,000 tons of lithium manganese iron phosphate, 75,000 tons of ultra-long cycle lithium iron phosphate, and 100,000 tons of lithium phosphate, as well as supplementing working capital [1] Corporate Governance - The company's board of directors has been authorized by the shareholders' meeting to make this adjustment without the need for further review [1]